# A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)

> **NCT02772575** · — · WITHDRAWN · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Liver Cancer
- Liver Metastases

## Interventions

- **PROCEDURE:** Hepatic trans-arterial embolization (TAE)
- **DEVICE:** MRI/CT scan
- **PROCEDURE:** biopsy
- **OTHER:** blood draw

## Key facts

- **NCT ID:** NCT02772575
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2017-01
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02772575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02772575, "A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT02772575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*